Gościniak, A.; Stasiłowicz-Krzemień, A.; Szeląg, M.; Pawlak, J.; Skiera, I.; Kwiatkowska, H.; Nowak, N.; Bernady, K.; Trzaskoma, P.; Zimak-Krótkopad, O.;
et al. Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability. Nutrients 2025, 17, 1939.
https://doi.org/10.3390/nu17111939
AMA Style
Gościniak A, Stasiłowicz-Krzemień A, Szeląg M, Pawlak J, Skiera I, Kwiatkowska H, Nowak N, Bernady K, Trzaskoma P, Zimak-Krótkopad O,
et al. Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability. Nutrients. 2025; 17(11):1939.
https://doi.org/10.3390/nu17111939
Chicago/Turabian Style
Gościniak, Anna, Anna Stasiłowicz-Krzemień, Marta Szeląg, Jakub Pawlak, Izabela Skiera, Hanna Kwiatkowska, Natasza Nowak, Krzysztof Bernady, Piotr Trzaskoma, Oskar Zimak-Krótkopad,
and et al. 2025. "Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability" Nutrients 17, no. 11: 1939.
https://doi.org/10.3390/nu17111939
APA Style
Gościniak, A., Stasiłowicz-Krzemień, A., Szeląg, M., Pawlak, J., Skiera, I., Kwiatkowska, H., Nowak, N., Bernady, K., Trzaskoma, P., Zimak-Krótkopad, O., & Cielecka-Piontek, J.
(2025). Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability. Nutrients, 17(11), 1939.
https://doi.org/10.3390/nu17111939
